Effect of Cabazitaxel on the QTc Interval in Cancer Patients

Exclusion Criteria

• •Conditions with screening ECG repolarization difficult to interpret, or showing significant abnormalities. This includes, but is not limited to: high degree AV block, pace-maker, atrial fibrillation or flutter
• •QTcF \>480 msec on screening Electrocardiogram (ECG)
• •Significant hypokalemia at screening (serum potassium \<3.5 mMol/L)
• •Significant hypomagnesemia at screening (serum magnesium \<0.7 mMol/L) (Note: Patient may be enrolled after correction of these laboratory abnormalities)
• •Patient receives (and cannot discontinue), or is scheduled to receive a QT-prolonging drug
• •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.